Reuters logo
BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharma enters into renewal agreement with Shanghai Pharma
May 10, 2017 / 10:19 AM / 5 months ago

BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharma enters into renewal agreement with Shanghai Pharma

May 10 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co

* Company and shanghai pharmaceuticals entered into renewal agreement

* Agreement for cooperation on innovative pharmaceuticals research & development for 3 years until 31 Dec 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below